Market News & Trends
Pulmatrix Shows iSPERSE Effectively Delivers Doses of Multi-Drug Formulations
Pulmatrix recently announced that data relating to the preclinical efficacy and multi-drug formulation and delivery capabilities of the company's novel iSPERSE inhaled dry powder drug…
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity
Tekmira Pharmaceuticals Corporation recently provided comments on presented data from a Phase I human clinical trial with ALN-VSP conducted by Alnylam Pharmaceuticals, Inc. ALN-VSP, an…
Alliqua Expands Patent Portfolio for Transdermal Drug Delivery Platform
Alliqua, Inc, an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, recently announced it has…
Evonik Degussa Provides Pharmaceutical Melt Extrusion Technology Services
Evonik Degussa Corporation recently announced the purchase of a Leistritz Nano 16-mm (TSE) Twin Screw Extruder to serve the growing number of customers using pharmaceutical…
6/21/2011
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity Tekmira Pharmaceuticals Corporation recently provided comments on presented data from a…
3M Signs Development Agreement; Updates Phosphagenics Collaboration
3M Drug Delivery Systems and Radius Health, Inc. recently announced an agreement to collaborate on the development of a transdermal delivery option of BA058, Radius'…
Ashland to Acquire International Specialty Products
Ashland Inc. and International Specialty Products Inc. (ISP) recently announced that Ashland has agreed to acquire privately owned ISP, a global specialty chemical manufacturer of…
Avantor Performance Materials Expands Presence in India
Avantor Performance Materials recently announced it has opened a new pharmaceuticals formulation applications laboratory at the RanQ Remedies facility, an established excipient developer and manufacturer…
Evotec Receives Milestone From Boehringer Ingelheim in Strategic Alliance
Evotec AG recently announced that a back-up compound in its strategic alliance with Boehringer Ingelheim has advanced into a Phase I clinical trial. Evotec will…
Protea Announces Completion of Human Clinical Trial for New Biopharmaceutical
Protea Biosciences, a leading developer of new technology for pharmaceutical research, recently announced that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has…
Rhenovia Enters Strategic Alliance With Portmann Instruments
Rhenovia Pharma SAS, a biotechnology company specialized in the development and optimization of treatments for diseases of the central and peripheral nervous systems, recently announced…
6/7/2011
Avantor Performance Materials Expands Presence in India Avantor Performance Materials recently announced it has opened a new pharmaceuticals formulation applications laboratory at the RanQ Remedies…
Talon Therapeutics to Commence Phase III Study of Marqibo
Talon Therapeutics, Inc. recently announced the initiation of a Phase III study of Marqibo (vincristine sulfate liposomes injection) in elderly patients with newly diagnosed aggressive…
TxCell Receives Approval for Phase I/II Clinical Trial Extension
TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical need, recently announced the approval…
Critical Outcome Technologies Initiates Development of Optimal Oral Oncology Formulation
Critical Outcome Technologies Inc. recently announced it has initiated a project to develop an optimal oral formulation of COTI-2. This lead oncology product has demonstrated…
Infinity Initiates Randomized Phase II Trial of Novel Hsp90 Inhibitor
Infinity Pharmaceuticals, Inc. recently announced the initiation of a Phase II clinical trial of retaspimycin hydrochloride (HCl), also known as IPI-504, the company's novel heat…
PolyPid Announces Revolutionary Drug Delivery System
PolyPid, a developer of innovative drug carriers, recently announced the company's flagship platform - PolyPid, an innovative family of drug carriers, based on a fusion…
Sartorius Stedim Biotech & RAUMEDIC Sign Partnership Agreement
Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM manufacturer of medical- and pharmaceutical-grade polymer components and…
5/24/2011
Sartorius Stedim Biotech & RAUMEDIC Sign Partnership Agreement Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM…
5/10/2011
QRxPharma Completes Patient Enrolment of Phase III Comparative Safety Study QRxPharma Limited recently announced it has completed patient enrolment for Study 022, a Phase III…
